-
Real-World Telehealth Utilization and Healthcare Costs in Commercially Insured Women With Breast Cancer: A Claims-Based Study
Mar 10, 2025, 14:00 PM -
Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study
Mar 10, 2025, 14:00 PM -
Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy
Mar 10, 2025, 14:00 PM -
Enhancing Patient Engagement in Pharmacist-Provided Medication Therapy Management for Chronic Conditions
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness (CEA) of Etonogestrel Subdermal Implant in a Brazilian Private Health Insurance
Mar 10, 2025, 14:00 PM -
Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis
Mar 10, 2025, 14:00 PM -
Economic Impact of Recurrence in High-Risk Early-Stage Estrogen-Receptor Positive (ER+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer (BC)
Mar 10, 2025, 14:00 PM -
Assessment of Racial Disparities in Prenatal Flu Vaccination in the United States
Mar 10, 2025, 14:00 PM -
Protocol for a Real-World Retrospective Study on Chronic Obstructive Pulmonary Disease Outcomes Among Individuals Switching to Heated Tobacco Products Compared to Continued and Former Cigarette Smokers in Japan
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D
Mar 10, 2025, 14:00 PM -
Pompe Disease in Sweden: A Real-World Evidence Study Investigating Healthcare Resource Utilisation and Costs
Mar 10, 2025, 14:00 PM -
Real-World Evidence on Health-Related Quality of Life in Older Women With Advanced Breast Cancer Treated With CDK 4/6 Inhibitors
Mar 10, 2025, 14:00 PM -
Payer Perceptions on Creating a National Value assessment Body in the US
Mar 10, 2025, 14:00 PM -
Patients' Experiences With Prescription Opioid Use for Acute and/or Chronic Pain Management: A Qualitative Study
Mar 10, 2025, 14:00 PM -
Demonstrating Broader Economic Impact of Oncology Diagnostics and Therapeutics on Healthcare Resource Utilization Across All Relevant Specialties
Mar 10, 2025, 14:00 PM -
Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Statins in Older Adults on Concomitant Triple Therapy (Oral Antidiabetic, RAS Antagonists, Statins)
Mar 10, 2025, 14:00 PM -
Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database
Mar 10, 2025, 14:00 PM -
Inclusion of Caregiver Costs and Quality of Life in Cost Effectiveness Analyses of Treatments for Neurological Conditions: Review of HTA Guidance Documents and Appraisals
Mar 10, 2025, 14:00 PM -
Practical Application of the ICER-developed Clinical Trial Diversity Rating Tool
Mar 10, 2025, 14:00 PM -
Health Equity and HTA: Is Equity Data Shaping Recommendations
Mar 10, 2025, 14:00 PM
